Neurodegenerative Diseases

Papers
(The TQCC of Neurodegenerative Diseases is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline19
Inflammatory Cytokine Levels in Patients with Sporadic Amyotrophic Lateral Sclerosis15
Association between Gut Microbiota with Mild Cognitive Impairment and Alzheimer’s Disease in a Thai Population13
Review of Available Data for the Efficacy and Effectiveness of Nabiximols Oromucosal Spray (Sativex®) in Multiple Sclerosis Patients with Moderate to Severe Spasticity11
Prevalence of Gastrointestinal Symptoms, Severity of Dysphagia, and Their Correlation with Severity of Amyotrophic Lateral Sclerosis in a Mexican Cohort9
Cerebrospinal Fluid Levels of 5-Hydroxyindoleacetic Acid in Parkinson’s Disease and Atypical Parkinsonian Syndromes9
The Immunomodulatory Potential Role of Mesenchymal Stem Cells in Diseases of the Central Nervous System6
Heart Rate Variability during Wake and Sleep in Huntington’s Disease Patients: An Observational, Cross-Sectional, Cohort Study5
Homoharringtonine Inhibits Alzheimer’s Disease Progression by Reducing Neuroinflammation via STAT3 Signaling in APP/PS1 Mice5
Synaptic Neurofilaments and GluN1-Neurofilament Light Chain Interaction in Experimental Models of α-Synucleinopathies5
Neuroprotective and Therapeutic Effects of Tocovid and Twendee-X on Aβ Oligomer-Induced Damage in the SH-SY5Y Cell Line4
Heart Rate Variability in Huntington Disease: A Long-Term Longitudinal Study3
Natural Age-Related Slow-Wave Sleep Alterations Onset Prematurely in the Tg2576 Mouse Model of Alzheimer’s Disease2
Clinical Manifestations Associated with the Domain-Containing Protein 2 Gene Mutation in an Iranian Family with Spastic Paraplegia 542
The Two-Way Route between Delirium Disorder and Dementia: Insights from COVID-192
Ecological Validity of the Montreal Cognitive Assessment in Non-Demented Parkinson’s Disease Patients2
Early Autonomic Symptoms Predict Functional Decline in Parkinson’s Disease Independent of Dopaminergic Therapy2
Hippocampal Functional Connectivity in Parkinson’s Disease2
Increased Intake of Fast-Acting Carbohydrates in Patients with Parkinson’s Disease2
Plasma Cystatin C Correlates with Plasma NfL Levels and Predicts Disease Progression in Parkinson’s Disease2
Sexuality and Neurodegenerative Disease: An Unmet Challenge for Patients, Caregivers, and Treatment2
Diagnostic Accuracy of Noun- and Verb-Naming Tasks in Detecting Cognitive Impairment in Parkinson’s Disease2
0.018450021743774